OneSource Specialty Pharma Limited (NSE:ONESOURCE)

NSE:ONESOURCE Cash Flow Statement

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	TTM	FY 2024	FY 2023
Period Ending	Dec 31, 2024	Mar 31, 2024	Mar 31, 2023
Net Income	-	-3,912	-7,998
Depreciation & Amortization	-	762.95	656.8
Loss (Gain) From Sale of Assets	-	-539.5	-
Asset Writedown & Restructuring Costs	-	-	7.11
Stock-Based Compensation	-	19.56	59.59
Other Operating Activities	-	2,702	8,788
Change in Accounts Receivable	-	-514.17	198.21
Change in Inventory	-	-4.03	-579.03
Change in Accounts Payable	-	-160.94	150.97
Change in Other Net Operating Assets	-	637.84	446.85
Operating Cash Flow	-	-1,072	-1,628
Capital Expenditures	-	-637.67	-439.95
Sale of Property, Plant & Equipment	-	3.97	-
Divestitures	-	-37.91	-
Investment in Securities	-	5,532	-
Other Investing Activities	-	245.36	-238.39
Investing Cash Flow	-	5,105	-678.34
Short-Term Debt Issued	-	3,525	1,034
Long-Term Debt Issued	-	3,907	528.52
Total Debt Issued	-	7,432	1,562
Short-Term Debt Repaid	-	-5,193	-926.05
Long-Term Debt Repaid	-	-5,112	-4,048
Total Debt Repaid	-	-10,305	-4,974
Net Debt Issued (Repaid)	-	-2,873	-3,411
Issuance of Common Stock	-	-	5,648
Other Financing Activities	-	-1,033	-1,053
Financing Cash Flow	-	-3,905	1,183
Net Cash Flow	-	127.9	-1,123
Free Cash Flow	-	-1,710	-2,068
Free Cash Flow Margin	-	-99.45%	-534.07%
Free Cash Flow Per Share	-	-41.15	-51.93
Cash Interest Paid	-	1,033	1,053
Cash Income Tax Paid	-	-	-109.31
Levered Free Cash Flow	-	-896.07	-
Unlevered Free Cash Flow	-	-362.33	-
Change in Net Working Capital	-	-471.57	-

Source: S&P Capital IQ. Standard template. Financial Sources.